Therefore, it is a feasible way to prevent and treat bone metastasis of breast cancer by inhibiting some cytokines and RANKL secreted by tumor cells, thereby inhibiting their activated downstream signal pathways. The gene discussed is TNFSF11; the disease is breast carcinoma.